GP-01CR21

N/A

Report date: 2022/01/14 15:29:27
NME

Base Information

Drug NameGP-01CR21
Drug Alias NameCXCR4-GPCRX3 inhibitor(GPCR Therapeutics)GP-01CR21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonistsC-X-C motif chemokine receptor 4 antagonists
TargetsG-protein coupled receptorC-X-C motif chemokine receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGPCR Therapeutics USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesGPCR Therapeutics USA Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A